Navigation Links
Align Technology Announces Second Quarter Fiscal 2008 Results
Date:7/29/2008

Q2'07

% Change % Change (a)

U.S. Orthodontists -- Full

Invisalign 14,830 2.3% (11.9%)

U.S. Orthodontists --

Invisalign Express 3,250 5.2% (3.6%)

U.S. GP Dentists -- Full

Invisalign 22,140 5.9% (2.7%)

U.S. GP Dentists --

Invisalign Express 4,970 0.4% 1.2%

International -- Full

Invisalign 9,520 16.1% 35.4%

International --

Invisalign Express 160 23.1% 45.5%

Total Cases Shipped 54,870 6.0% (0.3%)

Number of Doctors Cases

were Shipped to: Q2 08

U.S. Orthodontists 3,730

U.S. GP Dentists 11,030

International 2,910

Total Doctors Cases were

Shipped to Worldwide 17,670

Number of Doctors Trained

Worldwide: Q2 08 Cumulative

U.S. Orthodontists 100 8,510

U.S. GP Dentists 1,630 30,260

International 600 13,340

Total Doctors Trained Worldwide 2,330 52,110

Multiple Case Doctors

(Cumulative as of): Q2 08

U.S. Orthodontists 90.5%

U.S. GP Dentists 86.6%

International 77.2%

Doctors Starting Invisalign

Treatment (Cumulative as of): Q2 08

U.S. Orthodontists 6,920

U.S. GP Dentists 23,820

International 7,390

Total Doctors Starting

Invisalign Treatment 38,130

Doctor Utilization Rates*: Q2 08 Q1 08
'/>"/>

SOURCE Align Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Align Technology Executive to Present at Upcoming Financial Conferences
2. WellPoint Announces Realignment of Core Businesses; Names New Executives
3. Align Technology to Announce Third Quarter 2007 Financial Results on October 24, 2007
4. Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry
5. Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study
6. Threshold Pharmaceuticals Announces Corporate Realignment
7. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
8. Dallas Among the First to Offer Probiotic Supplement Align(R)
9. McGill researchers link enzyme to breast cancer malignancy
10. Breast Cancer Genes Also Raise Mens Risk for Malignancy
11. iNOS expression may links chronic biliary inflammation to malignant transformation
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Vivakor Announces New Acquisition Strategy 2Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences 56115 1Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences 56115 2Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 1Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 2Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 1Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 2Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 3Aging Population Heightened Consumer Awareness Propel U S Bone and Joint Health Ingredients Says Frost 26 Sullivan 56111 4